Article Information
- Received November 17, 2017
- Revision received March 12, 2018
- Accepted March 20, 2018
- Published online April 16, 2018.
Author Information
- Jenni E. Anttila1,
- Katrina Albert1,
- Emily S. Wires2,
- Kert Mätlik1,3,
- Lisa C. Loram4,
- Linda R. Watkins4,
- Kenner C. Rice2,
- Yun Wang2,5,
- Brandon K. Harvey2,* and
- Mikko Airavaara1,2,*
- 1Institute of Biotechnology, HiLIFE Unit, University of Helsinki, 00014, Finland
- 2Intramural Research Program, National Institute on Drug Abuse, IRP, NIH, Baltimore, MD 21224
- 3Medicum, Department of Pharmacology, University of Helsinki, 00014, Finland
- 4Department of Psychology & Neuroscience, University of Colorado, Boulder, CO 80309
- 5Center for Neuropsychiatric Research, National Health Research Institutes, Zhunan, 35053, Taiwan
- Correspondence should be addressed to either Brandon K. Harvey, PhD, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, 251 Bayview Blvd, Baltimore, MD 21224, E-mail: bharvey{at}intra.nida.nih.gov or Mikko Airavaara, PhD, Institute of Biotechnology, HiLIFE unit, P.O. Box 56 (Viikinkaari 5D), 00014 University of Helsinki, Finland; E-mail: mikko.airavaara{at}helsinki.fi.
Author contributions
Author contributions: JEA, BKH, and MA: conception and design; JEA, KA, ESW, KM, LCL, LRW, KCR, YW, BKH, and MA: collection and assembly of data, data analysis and interpretation, manuscript writing; BKH and MA: financial support and final approval of manuscript.
↵* B.K.H. and M.A. have equal contribution for the senior corresponding author position.
Disclosures
The authors declare no competing financial interests.
This work was supported by Academy of Finland grants: #250275, #256398, #281394, #309489; Biocentrum Helsinki; Sigrid Jusélius Foundation; EU FP7 GLORIA ID: 602919, 3iRegeneration funded by Tekes, and the National Institute on Drug Abuse, Intramural Research Program at the National Institutes of Health. KCR was also supported by the National Institute on Alcohol Abuse and Alcoholism. JEA was also funded by Ella and Georg Ehrnrooth Foundation, Päivikki and Sakari Sohlberg Foundation, Alfred Kordelin Foundation, and Orion Research Foundation.
Funding
Academy of Finland | Terveyden Tutkimuksen Toimikunta (Forskningsrådet för Hälsa)
250275; #256398; #281394Biocentrum Helsinki
Sigrid Juséliuksen Säätiö (Sigrid Jusélius Stiftelse)
EU FP7
GLORIA ID: 602919Tekes (Finnish Funding Agency for Innovation)
3iRegenerationNationtal Institute on Drug Abuse, Intramural research program, NIH, USA
Ella ja Georg Ehrnroothin Säätiö (Ella and Georg Ehrnrooth Foundation)
Päivikki and Sakari Sohlberg Foundation
Alfred Kordelinin Säätiö (Alfred Kordelin Foundation)
Orionin Tutkimussäätiö (Orion Research Foundation)
Other Version
- You are viewing the most recent version of this article.
- previous version (April 16, 2018).
Online Impact